Infographic: Moderna (MRNA) Q2 2023 Earnings Results

admin August 3, 2023

This article was originally published on Alpha Street

Moderna, Inc. (NASDAQ: MRNA) reported second quarter 2023 earnings results today.

Total revenue dropped to $344 million from $4.7 billion in the same period last year, mainly due to a decrease in sales of the company’s COVID-19 vaccine.

Net loss was $1.4 billion, or $3.62 per share, compared to net income of $2.2 billion, or $5.24 per share, last year.  

Product sales were $293 million, down 94% compared to last year, mainly due to lower sales volume. The company reported $0.3 billion in COVID-19 vaccine sales in Q2.

For FY2023, the company is expecting COVID-19 sales of $6-8 billion, dependent on US vaccination rates.

The post Infographic: Moderna (MRNA) Q2 2023 Earnings Results first appeared on AlphaStreet.

Categories: alpha-street

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to nests
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .